» Articles » PMID: 10675350

NF-kappaB Determines Localization and Features of Cell Death in Epidermis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2000 Feb 17
PMID 10675350
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Specialized forms of physiologic cell death lacking certain characteristic morphologic features of apoptosis occur in terminally differentiating tissues, such as in the outer cell layers of epidermis. In these cell layers, NF-kappaB translocates from the cytoplasm to the nucleus and induces target gene expression. In light of its potent role in regulating apoptotic cell death in other tissues, NF-kappaB activation in these cells suggests that this transcription factor regulates cell death during terminal differentiation. Here, we show that NF-kappaB protects normal epithelial cells from apoptosis induced by both TNFalpha and Fas, whereas NF-kappaB blockade enhances susceptibility to death via both pathways. Expression of IkappaBalphaM under control of keratin promoter in transgenic mice caused a blockade of NF-kappaB function in the epidermis and provoked premature spontaneous cell death with apoptotic features. In normal tissue, expression of the known NF-kappaB-regulated antiapoptotic factors, TRAF1, TRAF2, c-IAP1, and c-IAP2, is most pronounced in outer epidermis. In transgenic mice, NF-kappaB blockade suppressed this expression, whereas NF-kappaB activation augmented it, consistent with regulation of cell death by these NF-kappaB effector proteins. These data identify a new role for NF-kappaB in preventing premature apoptosis in cells committed to undergoing physiologic cell death and indicate that, in stratified epithelium, such cell death normally proceeds via a distinct pathway that is resistant to NF-kappaB and its antiapoptotic target effector genes.

Citing Articles

Rare variants in cause Van der Woude syndrome and other features of peridermopathy.

Robinson K, Robinson K, Singh S, Walkup R, Fawwal D, Adeyemo W medRxiv. 2025; .

PMID: 39867391 PMC: 11759255. DOI: 10.1101/2025.01.17.25320742.


Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications.

Blicharz L, Czuwara J, Rudnicka L, Torrelo A Clin Rev Allergy Immunol. 2023; 65(3):377-402.

PMID: 38103162 PMC: 10847199. DOI: 10.1007/s12016-023-08971-3.


Mammalian Epidermis: A Compendium of Lipid Functionality.

Vietri Rudan M, Watt F Front Physiol. 2022; 12:804824.

PMID: 35095565 PMC: 8791442. DOI: 10.3389/fphys.2021.804824.


Role of Apoptosis in Wound Healing and Apoptosis Alterations in Microgravity.

Riwaldt S, Corydon T, Pantalone D, Sahana J, Wise P, Wehland M Front Bioeng Biotechnol. 2021; 9:679650.

PMID: 34222218 PMC: 8248797. DOI: 10.3389/fbioe.2021.679650.


Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers.

Zhang X, Linder S, Bazzaro M Cancers (Basel). 2020; 12(4).

PMID: 32272746 PMC: 7226376. DOI: 10.3390/cancers12040902.


References
1.
Deveraux Q, Takahashi R, Salvesen G, Reed J . X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997; 388(6639):300-4. DOI: 10.1038/40901. View

2.
Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, Israel A . NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development. 1996; 122(7):2117-28. DOI: 10.1242/dev.122.7.2117. View

3.
Kinsella T, Nolan G . Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther. 1996; 7(12):1405-13. DOI: 10.1089/hum.1996.7.12-1405. View

4.
Wang C, Mayo M, Baldwin Jr A . TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 1996; 274(5288):784-7. DOI: 10.1126/science.274.5288.784. View

5.
Van Antwerp D, Martin S, Kafri T, Green D, Verma I . Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996; 274(5288):787-9. DOI: 10.1126/science.274.5288.787. View